Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Assembly approves bill allowing practice name on mifepristone, misoprostol labels at prescriber’s request
Summary
The Assembly passed a measure enabling prescribers to request that prescription labels for mifepristone and misoprostol display a health‑care practice name rather than an individual clinician’s name; supporters cite provider safety, opponents raised transparency and cross‑state legal concerns.
The Assembly on Wednesday approved bill 2145a (rules report 61), which allows a prescriber or dispensing practitioner to request that the prescription label for mifepristone and misoprostol display the name of a health‑care practice rather than the individual prescriber’s name.
Sponsor Assemblymember Jessica Reyes said the change responds to safety concerns for clinicians, saying the bill "would allow the prescription labels for mifepristone and misoprostol to include the name of a health care practice instead…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
